Pharmaceutical Services Negotiating Committee (PSNC) has written to the Health and Social Care Committee of House of Commons, suggesting a number of potential measures that could help minimise the impact of Brexit on medicines supply, pharmacies and patients.

The measure include allowing pharmacies to generically substitute certain medicines and relaxing the NHS Terms of Service obligation on pharmacists to better manage medicine supplies.

Using new Information Disclosure Regulations to monitor and communicate stock availability at pharmacies could help in timely interventions to minimise delays in procurement, the letter added.

PSNC also called for making Drug Tariff concession pricing more responsive to market prices and relaxing the restrictions on pharmacy-to-pharmacy wholesale dealing without wholesaler dealers licenses.

“We would like the Government to commit to protecting pharmacies where they are required to invest significant amounts of extra time sourcing and managing stocks, or where they incur significant financial costs as a result of medicines price increases,” Simon Dukes, chief executive of PSNC, said in the letter.

The letter follows a meeting last week with Sarah Wollaston MP, Chair of the Health and Social Care Committee.

Dukes welcomed the urgent consultation by the Department of Health and Social Care (DHSC) on giving pharmacists emergency powers to ration medicines in the event of a no-deal Brexit, saying the measure would assist in implementing many of the measures PSNC has suggested.

“We will continue to work closely with [DHSC] on the detail of that and we have committed to assisting their work in the event of there being a significant impact on the medicines supply chain after Brexit,” Dukes said in the letter.